TotalMarketCap

LivaNova

LIVNNasdaq United KingdomHealth CareBiotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$5.029 B

$91.30 -3.07%

Close of 6 Nov 2026

As of 6 Nov 2026, LivaNova (LIVN) has a market capitalization of $5.03B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.39B

#1334 by revenue

Earnings

-$242.5M

Loss-making

Shares outstanding

55,086,809

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →
  1. #1MedtronicMDT$134.3B
  2. #2LivaNovaLIVN$5.03B
  3. #3IntegerITGR$4.31B
  4. #4AxogenAXGN$2.92B
  5. #5TransMedics GroupTMDX$2.40B

What if LivaNova were worth as much as…

Open the what-if tool →

Gold $28.2T

$512,588.66

Per share 5,614× higher

Bitcoin $1.53T

$27,735.28

Per share 304× higher

Apple $5.02T

$91,052.34

Per share 997× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for LivaNova are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.